Health Insurance Innovations, Inc. (NYSE:HIIQ)‘s stock had its “buy” rating restated by investment analysts at Canaccord Genuity in a note issued to investors on Monday. They presently have a $39.00 price objective on the stock.

The analysts wrote, “We forecast supplemental policy growth of 15.9% which compares to 41.5% last year in 4Q’16, and 31.0% in the most recent quarter 3Q’17. We forecast IFP policy growth of 35.4% which compares to 58.1% last year in 4Q’16, and 45.6% in the most recent quarter 3Q’17. We also have a conservative estimate for gross margin (risk premium as % of premium equivalent). Based on these drivers, we think our revenue and adj-EBITDA estimates of $57.9M (+12.5% y/y) and $8.3M (-6.7% y/y) likely set the company up for another beat. If HIIQ posted similar policy growth as 3Q’17, implied 4Q’17 revenue and adj-EBITDA would be $67.6M and $9.6M, respectively.””

WARNING: This story was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The original version of this story can be accessed at

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with's FREE daily email newsletter.